Clinical Trial: A Study to Evaluate the Efficacy and Safety of UI022/UI023

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07600385) titled 'A Study to Evaluate the Efficacy and Safety of UI022/UI023' on May 14.

Brief Summary: Efficacy and Safety of Combined Cilostazol and Rosuvastatin Therapy Versus Rosuvastatin Alone in Patients with Chronic Lower Extremity Peripheral Artery Disease: A Multicenter, Double-Blind, Randomized Controlled Trial

Study Start Date: March 12, 2019

Study Type: INTERVENTIONAL

Condition: Peripheral Arterial Disease

Intervention: DRUG: UI022 or UI023 and co-administration of matching placebo

Run-in period: UIC201802 1 Tab/day + UIC201604 1 Tab/day, or UIC201803 1 Tab/day + UIC201801 1 Tab/day, for 4 weeks Treatment period: UI022 1 Tab/day + U...